Eric Kusnadi

648 total citations
12 papers, 362 citations indexed

About

Eric Kusnadi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Eric Kusnadi has authored 12 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 1 paper in Neurology. Recurrent topics in Eric Kusnadi's work include RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (4 papers) and Ubiquitin and proteasome pathways (3 papers). Eric Kusnadi is often cited by papers focused on RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (4 papers) and Ubiquitin and proteasome pathways (3 papers). Eric Kusnadi collaborates with scholars based in Australia, Spain and United States. Eric Kusnadi's co-authors include Richard B. Pearson, Ross D. Hannan, Jian Kang, Katherine M. Hannan, Luc Furic, Rodney J. Hicks, Jennifer R. Devlin, Denis Drygin, Carleen Cullinane and Gretchen Poortinga and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Eric Kusnadi

12 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Kusnadi Australia	10	284	77	51	32	28	12	362
Jin Woo Park South Korea	11	357 1.3×	52 0.7×	61 1.2×	26 0.8×	29 1.0×	19	406
Suet‐Yan Kwan United States	7	378 1.3×	56 0.7×	43 0.8×	28 0.9×	46 1.6×	9	474
Judith Pirngruber Germany	6	499 1.8×	88 1.1×	50 1.0×	26 0.8×	42 1.5×	8	559
Kuen‐Tyng Lin Taiwan	8	212 0.7×	80 1.0×	105 2.1×	55 1.7×	31 1.1×	11	310
Landon Wark Canada	10	206 0.7×	79 1.0×	46 0.9×	33 1.0×	47 1.7×	15	313
Leenus Martin United States	9	378 1.3×	86 1.1×	69 1.4×	55 1.7×	33 1.2×	11	476
Rei Mimoto Japan	9	244 0.9×	134 1.7×	76 1.5×	41 1.3×	27 1.0×	15	380
Caila Ryan United States	9	385 1.4×	67 0.9×	51 1.0×	26 0.8×	39 1.4×	9	456
Danton Ivanochko Canada	7	263 0.9×	88 1.1×	38 0.7×	22 0.7×	41 1.5×	13	328
Nina Weichert‐Leahey United States	6	334 1.2×	66 0.9×	100 2.0×	21 0.7×	37 1.3×	10	427

Countries citing papers authored by Eric Kusnadi

Since Specialization

Citations

This map shows the geographic impact of Eric Kusnadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Kusnadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Kusnadi more than expected).

Fields of papers citing papers by Eric Kusnadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Kusnadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Kusnadi. The network helps show where Eric Kusnadi may publish in the future.

Co-authorship network of co-authors of Eric Kusnadi

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Kusnadi. A scholar is included among the top collaborators of Eric Kusnadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Kusnadi. Eric Kusnadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ferreira, Rita, Katherine M. Hannan, Kostya I. Panov, et al.. (2024). Abstract PR004: Second generation RNA Polymerase I inhibitor PMR-116 targets ribsomal RNA synthesis to potently treat a broad spectrum of malignancies. Molecular Cancer Therapeutics. 23(11_Supplement). PR004–PR004. 1 indexed citations

Ormsby, Angelique R., Eric Kusnadi, Hamish E. G. McWilliam, et al.. (2022). Arginine-rich C9ORF72 ALS proteins stall ribosomes in a manner distinct from a canonical ribosome-associated quality control substrate. Journal of Biological Chemistry. 299(1). 102774–102774. 18 indexed citations

Peddigari, Suresh, Carol A. Mercer, Virginia Amador, et al.. (2021). Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death. Blood. 137(24). 3351–3364. 17 indexed citations

Kusnadi, Eric, et al.. (2021). Regulation of gene expression via translational buffering. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(1). 119140–119140. 29 indexed citations

Xie, Jianling, Eric Kusnadi, Luc Furic, & Luke A. Selth. (2021). Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer. Cancers. 13(13). 3254–3254. 13 indexed citations

Gao, Jixuan, MoonSun Jung, Chelsea Mayoh, et al.. (2020). Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression. Cancer Research. 80(17). 3706–3718. 18 indexed citations

Kusnadi, Eric, Anna Trigos, Carleen Cullinane, et al.. (2020). Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis. The EMBO Journal. 39(21). e105111–e105111. 28 indexed citations

Rebello, Richard J., Eric Kusnadi, Donald P. Cameron, et al.. (2016). The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer. Clinical Cancer Research. 22(22). 5539–5552. 61 indexed citations

Rebello, Richard J., Eric Kusnadi, Donald P. Cameron, et al.. (2016). The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer. European Journal of Cancer. 61. S167–S167. 10 indexed citations

10.

Kang, Jian, Eric Kusnadi, Rodney J. Hicks, et al.. (2016). Amino acid-dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcription. Oncotarget. 7(31). 48887–48904. 7 indexed citations

11.

Devlin, Jennifer R., Katherine M. Hannan, Nadine Hein, et al.. (2015). Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma. Cancer Discovery. 6(1). 59–70. 91 indexed citations

12.

Kusnadi, Eric, Katherine M. Hannan, Rodney J. Hicks, et al.. (2014). Regulation of rDNA transcription in response to growth factors, nutrients and energy. Gene. 556(1). 27–34. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact